Farwell Wildon - Insider Non-Derivative Transactions at Dyne Therapeutics, Inc. (DYN) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 19, 2024, Farwell Wildon's relationship to Dyne Therapeutics, Inc. (DYN) is Officer (Chief Medical Officer), and currently has 143,483 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other DYN insiders.
Data Source: SEC.
Farwell Wildon - Insider Non-Derivative Transactions of DYN Common Stock
Farwell Wildon - Insider Non-Derivative Transactions at DYN
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 20, 2024 | Sell -- (Common Stock) | 261 | 46 | 143222 |
| Aug 20, 2024 | Sell -- (Common Stock) | 2060 | 45.01 | 143483 |
| Jun 12, 2024 | Sell -- (Common Stock) | 1008 | 31.27 | 145543 |
| Jun 12, 2024 | Sell -- (Common Stock) | 1628 | 31.27 | 146551 |
| May 17, 2024 | Sell -- (Common Stock) | 425 | 28.59 | 148179 |
| May 17, 2024 | Sell -- (Common Stock) | 1956 | 28.2 | 148604 |
| Mar 13, 2024 | Sell -- (Common Stock) | 1030 | 25.58 | 150560 |
| Mar 12, 2024 | Sell -- (Common Stock) | 1585 | 25.7 | 151590 |
| Mar 8, 2024 | Sell -- (Common Stock) | 1557 | 26.2 | 153175 |
| Mar 8, 2024 | Sell -- (Common Stock) | 8364 | 25.8 | 154732 |
| Feb 29, 2024 | Sell -- (Common Stock) | 407 | 25 | 163096 |
| Feb 13, 2024 | Sell -- (Common Stock) | 5493 | 25.07 | 163503 |
| Jan 27, 2024 | Sell -- (Common Stock) | 100 | 25 | 168996 |
| Dec 13, 2023 | Sell -- (Common Stock) | 978 | 10.55 | 169096 |
| Dec 12, 2023 | Sell -- (Common Stock) | 1688 | 10.72 | 170074 |
| Nov 16, 2023 | Acquisition -- (Common Stock) | 82512 | 0 | 171762 |
| Sep 13, 2023 | Sell -- (Common Stock) | 1707 | 10.41 | 89250 |
| Jun 14, 2023 | Sell -- (Common Stock) | 1698 | 12.43 | 90957 |
| Mar 15, 2023 | Sell -- (Common Stock) | 7441 | 13.33 | 92655 |